Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese Subjects”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00788294
What this trial is testing

Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously

Who this might be right for
Healthy Volunteers
Pfizer 76
Early research (Phase 1)Study completedNCT00696865
What this trial is testing

AZD2624 Multiple Ascending Dose Study in Japan

Who this might be right for
HealthySafety
AstraZeneca 30
Early research (Phase 1)Study completedNCT02171000
What this trial is testing

Safety, Pharmacokinetics and Pharmacodynamics After Multiple Oral Doses of BIBR 1048 MS Capsule in Healthy Japanese Male Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 7
Early research (Phase 1)Study completedNCT02059330
What this trial is testing

Investigate Palbociclib (PD-0332991) Pharmacokinetics In Healthy Subjects Of Japanese Descent Relative To Healthy Non-Asian Subjects, And To Determine If Changes In Palbociclib Dose Result In Proportional Changes In Palbociclib Plasma Exposure In Japanese Subjects

Who this might be right for
Healthy
Pfizer 27
Early research (Phase 1)Study completedNCT01202734
What this trial is testing

A Pharmacokinetics and Safety of Methylphenidate HCl in Healthy Japanese Adult Male Volunteers

Who this might be right for
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 10
Early research (Phase 1)Study completedNCT01978652
What this trial is testing

Pharmacokinetic Study of Peginterferon Beta-1a in Japanese and Caucasian Adult Healthy Participants.

Who this might be right for
Healthy
Biogen 44
Early research (Phase 1)Study completedNCT00479349
What this trial is testing

Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 32
Early research (Phase 1)Study completedNCT01854216
What this trial is testing

Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian Subjects

Who this might be right for
Healthy
UCB BIOSCIENCES GmbH 26
Early research (Phase 1)Ended earlyNCT01818011
What this trial is testing

A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects

Who this might be right for
Infections, Bacterial
GlaxoSmithKline 12
Early research (Phase 1)Study completedNCT03808493
What this trial is testing

A Bioequivalence (BE) Study of TAK-438 Orally Disintegrating (OD) Tablet

Who this might be right for
Japanese Healthy Adult Male
Takeda 48
Early research (Phase 1)Study completedNCT01152671
What this trial is testing

RO5024048 in Japanese and Caucasian Healthy Volunteers

Who this might be right for
Healthy Volunteer
Hoffmann-La Roche 97
Early research (Phase 1)Study completedNCT01273506
What this trial is testing

Compare the Bioequivalence of 50-mg Tapentadol (CG5503) Dose Administered as Two 25-mg Tablets Relative to One 50-mg Tablet

Who this might be right for
Healthy Volunteer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 30
Early research (Phase 1)Study completedNCT04464681
What this trial is testing

Multiple Dose Escalation Study of M201-A in Healthy Japanese Subjects

Who this might be right for
Healthy Volunteers
Kitasato University 18
Early research (Phase 1)Study completedNCT00619736
What this trial is testing

Study Evaluating the Safety, Tolerability and Pharmacokinetics of NSA-789 in Healthy Japanese Male Subjects

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer 56
Early research (Phase 1)Study completedNCT01776463
What this trial is testing

A Healthy Subject Study With Z-360 and Placebo

Who this might be right for
Healthy Volunteers
Zeria Pharmaceutical 43
Early research (Phase 1)Study completedNCT04155567
What this trial is testing

Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male Participants

Who this might be right for
Healthy Volunteers
Takeda 10
Early research (Phase 1)Study completedNCT01335451
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AZD5213 After Single and Multiple Ascending Oral Doses in Healthy Young and Elderly Japanese Subjects

Who this might be right for
Healthy
AstraZeneca 48
Early research (Phase 1)Study completedNCT01537653
What this trial is testing

Safety, Tolerability and Pharmacokinetics of SAR231893 (REGN668) in Healthy Japanese Adult Male Subjects

Who this might be right for
Healthy
Sanofi 32
Early research (Phase 1)Ended earlyNCT01983566
What this trial is testing

Effect of Food and Increased Gastric pH Value on Bioavailability of a Single Dose of BI 207127 in Healthy Caucasian and Japanese Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 16
Early research (Phase 1)Study completedNCT01994668
What this trial is testing

Phase 1 Study to Characterize the Safety and Pharmacokinetics of Single Intravenous Dose of Lorazepam in Healthy Japanese Adult Subjects

Who this might be right for
Healthy
Pfizer 8
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation